Fundraising Fox

TiGenix

Tokyo, JP · Belgium corporation · 3 known investors

takeda.com ↗

Takeda is a global pharmaceutical company that develops medicines and healthcare solutions across multiple therapeutic areas to improve patient outcomes and expand access to care.

BiotechDigital HealthHealthtechin /takeda-pharmaceuticals

Founders & leadership

CD
Claudia D'AugustaExecutive Officer
JA
June AlmenoffDirector
RG
Russell GreigDirector
EB
Eduardo Bravo Fernandez de AraozExecutive Officer, Director
JS
Jean StephenneDirector
MP
Marie Paule RichardExecutive Officer
WD
Willy DuronDirector
WD
Wilfried DalemansExecutive Officer

Investors · 3

Rho VenturesNew York · $2M – $15M
Ysios CapitalBarcelona · $5.4M – $21.6M
Kreos CapitalreportedLondon

Reported raises · per SEC filings

Form D private placements
▶$25.9KraisedJan 2018 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Claudia D'AugustaExecutive Officer
  • June AlmenoffDirector
  • Russell GreigDirector
  • Eduardo Bravo Fernandez de AraozExecutive Officer, Director
  • Jean StephenneDirector
  • Marie Paule RichardExecutive Officer
  • Willy DuronDirector
  • Wilfried DalemansExecutive Officer
Offering amount
$195.4K
Amount sold
$25.9K
First sale
Nov 2017
Incorporated
Corporation, Belgium
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news